Expression of these EMT-inducers is regulated by MAPK and PI3K signaling, therefore, the effect of fisetin, sorafenib and their combination on the expression of these EMT-inducing transcription factors in BRAF-mutated melanoma cells was also determined. This evidence concerns the gene BRAF and melanoma.